English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sang Eun Park1,7, Hye Jin Yi1, Nayoung Suh9, Yun-Yong Park2,5, Jae-Young Koh3,4,6, Seong-Yun Jeong1,2,5, Dong-Hyung Cho8, Choung-Soo Kim1,4,7 and Jung Jin Hwang1,2,5 1Institute for Innovative Cancer Research, Asan Medical Center, Seoul, Korea 2Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea 3Department of Neurology, Asan Medical Center, Seoul, Korea 4Department of Urology, Asan Medical Center, Seoul, Korea 5Department of Convergence Medicine, University of Ulsan, College of Medicine, Seoul, Korea 6Neural Injury Research Lab, University of Ulsan, College of Medicine, Seoul, Korea 7Department of Urology, University of Ulsan, College of Medicine, Seoul, Korea 8Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Korea 9Department of Medicine Engineering, Soon Chun Hyang University, College of Medical Sciences, Asan, Korea

Correction: Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-κB